Evolus Inc. [NASDAQ: EOLS] price surged by 71.65 percent to reach at $5.13. The company report on February 20, 2021 that Evolus to Participate in the 10th Annual SVB Leerink Global Healthcare Conference.
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced that members of management will be participating in the 10th Annual SVB Leerink Global Healthcare Conference.
A sum of 33762520 shares traded at recent session while its average daily volume was at 1.39M shares. Evolus Inc. shares reached a high of $14.81 and dropped to a low of $9.55 until finishing in the latest session at $12.29.
The one-year EOLS stock forecast points to a potential downside of -27.09. The average equity rating for EOLS stock is currently 2.20, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Evolus Inc. [EOLS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EOLS shares is $9.67 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EOLS stock is a recommendation set at 2.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Mizuho have made an estimate for Evolus Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on July 07, 2020. The new note on the price target was released on February 06, 2020, representing the official price target for Evolus Inc. stock. Previously, the target price had yet another raise to $25, while SVB Leerink analysts kept a Outperform rating on EOLS stock.
The Average True Range (ATR) for Evolus Inc. is set at 1.31, with the Price to Sales ratio for EOLS stock in the period of the last 12 months amounting to 4.36. The Price to Book ratio for the last quarter was 11.82, with the Price to Cash per share for the same quarter was set at 5.60.
EOLS Stock Performance Analysis:
Evolus Inc. [EOLS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 74.57. With this latest performance, EOLS shares gained by 112.26% in over the last four-week period, additionally plugging by 216.75% over the last 6 months – not to mention a rise of 17.38% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for EOLS stock in for the last two-week period is set at 82.75, with the RSI for the last a single of trading hit 85.75, and the three-weeks RSI is set at 80.32 for Evolus Inc. [EOLS]. The present Moving Average for the last 50 days of trading for this stock 5.45, while it was recorded at 8.40 for the last single week of trading, and 4.36 for the last 200 days.
Insight into Evolus Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Evolus Inc. [EOLS] shares currently have an operating margin of -271.40 and a Gross Margin at +65.22. Evolus Inc.’s Net Margin is presently recorded at -257.79.
Return on Total Capital for EOLS is now -68.37, given the latest momentum, and Return on Invested Capital for the company is -65.22. Return on Equity for this stock declined to -109.90, with Return on Assets sitting at -43.68. When it comes to the capital structure of this company, Evolus Inc. [EOLS] has a Total Debt to Total Equity ratio set at 121.51. Additionally, EOLS Total Debt to Total Capital is recorded at 54.85, with Total Debt to Total Assets ending up at 40.15. Long-Term Debt to Equity for the company is recorded at 120.00, with the Long-Term Debt to Total Capital now at 54.17.
Reflecting on the efficiency of the workforce at the company, Evolus Inc. [EOLS] managed to generate an average of -$383,123 per employee. Receivables Turnover for the company is 6.55 with a Total Asset Turnover recorded at a value of 0.17.Evolus Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 10.00 and a Current Ratio set at 10.40.
EOLS Stock EPS
With the latest financial reports released by the company, Evolus Inc. posted -0.47/share EPS, while the average EPS was predicted by analysts to be reported at -0.73/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 35.60%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EOLS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Evolus Inc. go to 16.50%.
Evolus Inc. [EOLS] Insider Position Details
There are presently around $95 million, or 22.20% of EOLS stock, in the hands of institutional investors. The top three institutional holders of EOLS stocks are: BLACKROCK INC. with ownership of 1,482,635, which is approximately -16.337% of the company’s market cap and around 3.60% of the total institutional ownership; SCHRODER INVESTMENT MANAGEMENT GROUP, holding 1,376,459 shares of the stock with an approximate value of $16.92 million in EOLS stocks shares; and VANGUARD GROUP INC, currently with $11.63 million in EOLS stock with ownership of nearly -0.921% of the company’s market capitalization.
Positions in Evolus Inc. stocks held by institutional investors increased at the end of April and at the time of the April reporting period, where 37 institutional holders increased their position in Evolus Inc. [NASDAQ:EOLS] by around 1,524,163 shares. Additionally, 43 investors decreased positions by around 1,124,348 shares, while 23 investors held positions by with 5,119,799 shares. The mentioned changes placed institutional holdings at 7,768,310 shares, according to the latest SEC report filing. EOLS stock had 18 new institutional investments in for a total of 711,180 shares, while 18 institutional investors sold positions of 484,398 shares during the same period.